Goldman Sachs’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.63M | Buy |
|
|||||
|
2025
Q2 | $904K | Sell |
|
|||||
|
2025
Q1 | $1.49M | Buy |
|
|||||
|
2024
Q4 | $1.43M | Sell |
|
|||||
|
2024
Q3 | $1.94M | Buy |
|
|||||
|
2024
Q2 | $668K | Sell |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $181K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $40.5K | Buy |
|
|||||
|
2023
Q1 | $10.9K | Sell |
|
|||||
|
2022
Q4 | $102K | Sell |
|
|||||
|
2022
Q3 | $1.15M | Buy |
|
|||||
|
2022
Q2 | $386K | Buy |
|
|||||
|
2022
Q1 | $657K | Buy |
|
|||||
|
2021
Q4 | $594K | Buy |
|